Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001780649-26-000002

CEO and Chairman sold 124,998 shares at $18.44 ($2,304,963)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROBINS CHAD M · CEO and Chairman

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2026-02-02 Sale : show line 1 in the form 10b5-1 −124,998 $18.44 $2,304,963 2,459,245 D
Open-market sales · 124,998 sh · avg $18.44 · $2,304,963
Loading xslF345X05/primary_doc.xml…